Gum resin as a carrier for topical application of pharmacologically active agents
The invention provides a biological dressing for treatment of a dermatological disease comprised of a gum resin, a topically acceptable volatile solvent, and a pharmacologically active agent. The gum resin is present in a suitable amount that the composition, when the solvent evaporates, will dry to form a solid coating that sticks to the skin or mucosal membrane to which the composition is applied and maintain the pharmacologically active agent over a sustained period of time in contact with sites on the skin or mucosal membranes exhibiting symptoms of the disease. Methods are provided for treating symptoms of dermatological diseases with such a pharmacological composition. Biological dressings including tincture of benzoin and clotrimazole are shown to be efficacious for the long-term amelioration of symptoms of athlete's foot.
1. A pharmacological composition comprising: a) a gum resin, wherein said gum resin comprises benzoin; b) at least one topically acceptable pharmacologically active agent other than said gum resin that is effective as a treatment for ameliorating symptoms of a disease of skin or a mucous membrane of a mammal, wherein said pharmacologically active agent can remain in contact with said skin or said mucous membrane greater than 6 hours without toxic effects to said mammal; and c) a topically acceptable volatile solvent for said gum resin and said pharmacologically active agent.
2. The composition according to claim 1 , wherein said topically acceptable volatile solvent comprises ethanol.
3. The composition according to claim 2 , wherein said topically acceptable volatile solvent is ethanol and comprises about 60% to 90% of said composition.
4. The composition according to claim 1 wherein said pharmacologically active agent is an antimicrobial agent.
5. The composition according to claim 4 , wherein said antimicrobial agent is an anti-fungal agent.
6. The composition according to claim 5 , wherein said anti-fungal agent is clotrimazole.
7. The composition according to claim 6 , wherein said clotrimazole is present as 1% of said composition.
8. The composition according to claim 1 wherein said pharmacologically active agent is a steroidal agent.
9. The composition according to claim 8 , wherein said steroidal agent is betamethasone.
10. The composition according to claim 9 , wherein said betamethasone is present as 0.025-0.05% of the composition.
11. The composition according to claim 1 , wherein said pharmacologically active agent comprises both an antimicrobial agent and a steroidal agent.
12. The composition according to claim 1 , further comprising a penetration enhancer.
13. A pharmacological composition comprising: a) a benzoin; b) clotrimazole; and c) ethanol.
14. A pharmacological composition comprising: a) a benzoin; b) 1% clotrimazole; and c) 60% ethanol.
15. The composition according to claim 4 , wherein said antimicrobial agent is an anti-viral agent.
16. The composition according to claim 4 , wherein said antimicrobial agent is an anti-bacterial agent.
17. The composition according to claim 16 wherein said antibacterial agent is an antibiotic.
18. The composition according to claim 1 wherein said pharmacological agent is a hormone.
19. The composition according to claim 1 wherein said pharmacological agent is an anti-histamine.
20. The composition according to claim 5 , wherein said anti-fungal agent is terbinafine.
21. The composition according to claim 19 , wherein said terbinafine is present as 1% of said composition.
22. A pharmacological composition comprising: a) a benzoin; b) terbinafine; and c) ethanol.
23. A pharmacological composition comprising: a) a benzoin; b) 1% terbinafine; and c) 60% ethanol.
24. A pharmacological composition comprising: a) a benzoin; b) ciclopirox olamine; and c) ethanol.
25. A pharmacological composition comprising: a) a benzoin b) 1% ciclopirox olamine; and c) 60% ethanol.